Skip to main content
. 2018 Jun 25;41(8):1717–1725. doi: 10.2337/dc18-0787

Figure 1.

Figure 1

Insulin doses and corresponding fasting glucose values over time while on glargine treatment. A: Mean fasting morning SMBG values every 2 weeks over 12 weeks. B: Mean glargine dose corresponding to each SMBG value. C: Corresponding percentage of participants who achieved the goal fasting SMBG of 4.4–5.0 mmol/L every 2 weeks. Data are mean (95% CI).